Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VCAM study: VZV vaccine to induce antitumor immunity in CML and MDS
jRCTs051180106Completed
- Sponsor
- Research Foundation for Microbial Diseases of Osaka University
- Start
- May 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of varicella vaccine in chronic myelogenous leukemia (CML) and myelodysplastic syndrome (MDS) (2 arms), sponsored by Research Foundation for Microbial Diseases of Osaka University. Primary endpoint: Tumor-specific CTL induction. Started May 2018; status: completed.
02
Drugs
varicella vaccine
03
Conditions
chronic myelogenous leukemia (CML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on jRCTs051180106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180106.